Member Info for Dibs61

A question for you chdunn. According to The Daily SP chart the price is very slowly creeping up after the initial spike then drop. When can we expect the SP to dip below 30?

LB28 - actually it’s nearer 1.5 million tests per month but let’s not split hairs!

It’s fantastic news and in ADDITION to the rapid POC Test that we can expect design freeze announcement quite soon I suspect. This was totally unexpected but completely logical when you think about ODX expertise in ELISA tests.

Very happy indeed.

Oh and one other thing, ODX have a close working relationship with the Burnet Institute in Australia who were the original ‘inventors’ of Visitect CD4. Burnet are also working hard on an antibody Test and they have top quality pedigree. So this is what I mean when I say ODX are platform agnostic (a term I have taken from a former senior employee of the company). They have more than one iron in the fire and will be pragmatic when it comes to making the test.

Don’t make the mistake of looking at this through a narrow lens, be that finances or whatever.

And DYOR and if you have concerns talk to the company.

The company are platform agnostic. The government policy is that the test will be ‘open access’. There will be no single winner. It will be a national collaborative effort. BUT is anyone seriously questioning that ODX will not play an important role in that effort? ODX are without question very well placed to do so. I have read an absurd amount of talk about cash shortages blah blah. Try and understand this is not a conventional AIM market situation. This is a matter of massive national and political importance. The government, both UK AND don’t forget the Scottish government, as well as Scottish Enterprise, are right behind this initiative. Cash will not be an issue for the test. . I keep a dialogue with the company and they are not concerned about cash. They are EBITDA positive and have not yet seen any significant impact on their ‘normal’ revenues as a result of the virus. Operationally they continue as normal as possible within govt guidelines at the Alva and ELy facilities. Non ops staff are as you would expect working from home.

The bottom line is that when a test is approved, whether it comes from the UK RTC, or some other source, Mologic or whoever, be in no doubt ODX WILL be making it along with other manufacturers. ODX current annual sales are in the £9m - £10m range. I have it on good authority that ODX can manufacture up to 1m tests pm from Alva. I think that could generate an additional £2m-£4m revenue pm on top of existing revenue (much of which is manufactured from Ely). This kind of revenue growth is transformational hockey stick stuff for the company and warrants a big rerating.

Shareseeker - the government statement by the Prof was made today 18th

National Testing Co-Ordinator Professor John Newton said today in a government press release :

“We are breaking new ground with this work every day and I am confident this major research effort will make a breakthrough.”

The above statement made in relation to Antibody Tests.

I will listen to the Good Professor not Noddy know nothing think they know it all posters. Thanks ;)

Someone has way too much spare time on their hands lol.

You have to admire their sense of altruism though. We are truly grateful.

(of course sods law now I've said that it'll dip) But the instruction from the seller(s) to the broker today seems to be to get a minimum price of 28p. There has been no trades of any significance under that level. So, at the start of the trading day MM's get a feel of demand and where that balance is between supply and demand and then can set the level with the agreement of the seller. It's all being worked to perfection from their POV. And we are left frustrated.

I think the issue, as someone else alluded to elsewhere is that we have stale institutional bulls here. The likes of Octopus, Oryx and, not forgetting L&G - definitely not forgetting L&G have all been invested here for a long time but have been 'trapped' due to the perennial lack of liquidity here. With the massive retail demand for the stock they have an opportunity, which they may have preferred for some while, to either reduce their stake or exit. I'm pretty sure Oryx are either now under 3% or out altogether. My attention is now turned to L&G. I sincerely hope they are not offloading as well now.

Talk about filling an order!

Ok maybe we can push on now.

Dare I say it was that 200k + trade the final sell out? Bid has been rising steadily since.

themuir. Get your facts right. It is NOT a contract it is an MOU. You clearly don't understand the difference. And NOWHERE does it say it will take 6 months. Its says the MOU runs for 6 months. That is something entirely different.

Now you had no effective argument at all against the points I made. You simply decided to snipe and have a go because you can't take responsibility for your **** investment decisions. I have never taken other posters advice but made MY own decisions and maybe if you had you wouldnt have lost so much money.

Surginator - L2 2 v1

Yes the SP may be stagnating but the volume certainly isn't! Over 7m traded already today. Thats a good thing. Masses of retail demand. Just need our Oryx seller to complete. It certainly should be today latest allowing a preweekend rally later?

Worth also adding that ODX's collaboration partner for CD4 (Burnet) are also beavering away on antibody test development too. I would not be surprised if they turn up with something and the interesting thing then will be will they partner with ODX again? They have a good working relationship.

We'll see muir. ODX are the ONLY company across the entire globe who have managed to develop a rapid POC instrument free CD4 test. It is CE marked, is close to WHO prequalification and ODX not only have lateral flow test expertise but they have another iron in the fire being the only company in the consortium with ELISA expertise too. They also have a separate collaboration with the Burnet Institute in Australia who came up with the original model for Visitect CD4.

Sometimes the little guys can be a lot more nimble on their feet than the big conglomerates.

And on the basis of what I have said IMO it will not take 'months and months'. They do not need to recreate the wheel here.

Design freeze announcement next week.

Which bit of "the arrangement is not expected to impact Fusion's revenue" do people here not understand?

Unbelievable.

spurs - it doesn't need the ramping it really doesn't. ;)

Over 14m traded now today. Incredible volume. Rough calculation on the regular 50k trades (which I think are Oryx) another 1.5 to 2 million offloaded. They could be under 3% now. Expecting more Holdings RNS's.

By my calculation, since last Thursday up to one third of the companies entire share capital has been traded. Considering the normal illiquidity of this stock that on its own is remarkable. We will surely be seeing more Holdings RNS's.

Oh yes Tony, we are definitely not a one trick pony that’s for sure.

Now, ODX do like a Thursday RNS........

spurs - LTH here. Oryx not necessarily out. They do increase/reduce their stake from time to time. They ‘may’ have done but I suspect they’ve kept a core stake of maybe up to 5% so they just finished offloading earlier this pm.

I’d be amazed to see 50p tomorrow but then maybe I’ve been here too long! I do hope to see it soon though.

GLA and DYOR

Mikey279 Mickey Mouse Test?! Oh dear You need to do some research Pronto